Avalon Ventures Management, LLC Janux Therapeutics, Inc. Put Options Transaction History

Avalon Ventures Management, LLC

  • $14.2 Billion
  • Q3 2025

Put Options

0 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
No transaction found.

About Janux Therapeutics, Inc.

JANX Quotes by TradingView
  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $1.22B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track Avalon Ventures Management, LLC Portfolio

Follow Avalon Ventures Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Ventures Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Ventures Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email